Skip to content

Mindful Non-reactivity, Anxiety, Depression, and Perceived Stress as Mediators of the Mindfulness Virtual Community Intervention: Pathways to Enhance Mental Health in University Students (Preprint)

Meysam Pirbaglou, Christo El Morr, Farah Ahmad, Paul Ritvo

September 22, 2024 DOI: 10.2196/preprints.65853 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Secondary mediation analysis of two randomized controlled trials
Population Student participants from two randomized controlled trials
Intervention Mindfulness Virtual Community (MVC)
Duration 8 weeks
Measures Five-Factor Mindfulness Questionnaire (non-reactivity facet), depression, anxiety, perceived stress, quality of life
Topics Anxiety Depression Meditation
Key findings The MVC intervention showed significant 8-week effects on depression, anxiety, perceived stress, quality of life, and mindful non-reactivity relative to waitlist control. Mediation analysis supported mindful non-reactivity, depression, anxiety, and perceived stress as mediators, leading the authors to argue that mindful non-reactivity, depression, and anxiety are key mechanisms of the intervention's benefits.

Abstract

Background: Mindfulness-based interventions (MBIs) are widely employed in mental health promotion and treatment. Despite widespread evidence of effectiveness in different populations and delivery modes, there are sparse findings concerning mechanisms of action in these interventions.

Objective: This study, based on a secondary evaluation of two randomized controlled trials (RCTs) with student participants, was aimed at understanding mediators of the Mindfulness Virtual Community (MVC) intervention, an 8-week, multi-component, online mindfulness cognitive-behavioral intervention.

Methods: Mediation analysis, using structural equation modeling with bootstrap resampling, was used to assess direct and indirect relationships between intervention and study outcomes. In accord with the intervention’s theoretical perspective and direct effects patterns, a model was specified to evaluate whether mindful non-reactivity, as evaluated by the five-factor mindfulness questionnaire, mediated relationships between the MVC intervention and anxiety and depression (as symptom-driven outcomes), and perceived stress and quality of life (as functional outcomes). The model included additional mediating paths for perceived stress through anxiety and depression, and for quality of life through perceived stress. The model was subsequently adjusted for baseline differences in other mindfulness (i.e. observing, describing, activity with awareness, non-judgement, and non-reactivity) facets.

Results: Direct effects evaluations indicated statistically significant differences at 8 weeks between the MVC intervention and waitlist control (WLC) group on depression (-1.65, P=.003), anxiety (-3.29, P<.001), perceived stress (-2.28, P=.001), and quality of life (4.07, P=.003), and the non-reactivity facet of mindfulness (1.55, P=.001). Mediation analysis supported the mediating roles of the non-reactivity facet of mindfulness, depression, anxiety and perceived stress through single and sequential mediation paths. Results indicated acceptable fit characteristics for the main (CFI=.984; RMSEA=.068; SRMR=.045) and extended (CFI=.978; RMSEA=.078; SRMR=.040) models.

Conclusions: This research underscores the importance of mindful non-reactivity, depression, and anxiety as key mediators of MVC intervention benefits. CLINICALTRIAL

Trial Registration: https://doi.org/10.1186/ISRCTN12249616 Registration Date: 21/06/2017

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Explore topics